Seattle Genetics


Merck To Buy $1B Seattle Genetics Stake For Oncology Collab

Seattle Genetics (SGEN) shares are up 9% in pre-market hours today following the news that Merck will make a $1 billion equity investment …

Seattle Genetics’ Breast Cancer Drug Approved Months Ahead of Schedule

Seattle Genetics (SGEN) has announced that its drug TUKYSA (tucatinib) has been approved by the FDA for metastatic HER2 positive breast cancer patients, …

Company Update (NASDAQ:SGEN): Seattle Genetics, Inc. Announces Multiple ADCETRIS® Data Presentations at the International Conference on Malignant Lymphoma

Seattle Genetics, Inc. (NASDAQ:SGEN) announced several ADCETRIS (brentuximab vedotin) data presentations at the 13th International Conference on Malignant Lymphoma (ICML) being held June …

Company Update (NASDAQ:SGEN): Seattle Genetics, Inc. and Unum Therapeutics Enter into Strategic Cancer Immunotherapy Collaboration

Seattle Genetics, Inc. (NASDAQ:SGEN) and Unum Therapeutics announced that the two companies have entered into a strategic collaboration and license agreement to develop …

Stock Update (NASDAQ:SGEN): Seattle Genetics, Inc. Highlights ADCETRIS® Data Presentations in the AETHERA Post-Transplant Consolidation Setting and in Frontline DLBCL

Seattle Genetics, Inc. (NASDAQ:SGEN) announced several ADCETRIS (brentuximab vedotin) data presentations in the AETHERA post-transplant consolidation setting for Hodgkin lymphoma (HL) and in …

Stock Update (NASDAQ:SGEN): Seattle Genetics, Inc. Announces Clinical Data Presentations from Multiple Antibody-Drug Conjugate (ADC) Programs at ASCO Annual Meeting

Seattle Genetics, Inc. (NASDAQ:SGEN) announced that data from multiple proprietary and collaborator antibody-drug conjugate (ADC) programs will be highlighted in more than 10 …

Zacks’ Bull Of The Day: Seattle Genetics

Seattle Genetics (NASDAQ:SGEN) is a $4 billion biotechnology company focused on developing and commercializing innovative antibody-based therapies for the treatment of cancer. They …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts